Literature DB >> 23760860

Inferior survival for young patients with contralateral compared to unilateral breast cancer: a nationwide population-based study in the Netherlands.

A Font-Gonzalez1, L Liu, A C Voogd, M K Schmidt, J A Roukema, J W W Coebergh, E de Vries, I Soerjomataram.   

Abstract

To compare overall survival between women with unilateral breast cancer (UBC) and contralateral breast cancer (CBC). Women with UBC (N = 182,562; 95 %) and CBC (N = 8,912; 5 %) recorded in the Netherlands Cancer Registry between 1989 and 2008 were included and followed until 2010. We incorporated CBC as a time-dependent covariate to compute the overall mortality rate ratio between women with CBC and UBC. Prognostic factors for overall death were examined according to age at first breast cancer. Women with CBC exhibited a 30 % increase in overall mortality (Hazard Ratio (HR), 95 % Confidence Interval: 1.3, 1.3-1.4) compared with UBC, decreasing with rising age at diagnosis of first breast cancer (<50 years: 2.3, 2.2-2.5 vs. ≥70 years: 1.1, 1.0-1.1). Women older than 50 years at CBC diagnosis and diagnosed 2-5 years after their first breast cancer exhibited a 20 % higher death risk (1.2, 1.0-1.3) compared to those diagnosed within the first 2 years. In women younger than 50 years, the HR was significantly lower if the CBC was diagnosed >5 years after the first breast cancer (0.7, 0.5-0.9). The prognosis for women with CBC significantly improved over time (2004-2008: 0.6, 0.5-0.7 vs. 1989-1993). Women with CBC had a lower survival compared to women with UBC, especially those younger than 50 years at first breast cancer diagnosis. A tailored follow-up strategy beyond current recommendations is needed for these patients who, because of their age and absence of known familial risk, are currently not invited for population-based screening.

Entities:  

Mesh:

Year:  2013        PMID: 23760860     DOI: 10.1007/s10549-013-2588-9

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  11 in total

1.  Double Trouble: Contralateral Breast Cancer Risk Management in the Modern Era.

Authors:  Kevin J Cheung; Nancy E Davidson
Journal:  J Natl Cancer Inst       Date:  2019-07-01       Impact factor: 13.506

2.  Incidence of metachronous contralateral breast cancer in the Canton of Zurich: a population-based study of the cancer registry.

Authors:  Julia Prater; Fabio Valeri; Dimitri Korol; Sabine Rohrmann; Silvia Dehler
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-23       Impact factor: 4.553

3.  Clinical characteristics and the associated risk factors of the development of bilateral breast cancers: A case-control study.

Authors:  Sumadi Lukman Anwar; Dayat Prabowo; Widya Surya Avanti; Ery Kus Dwianingsih; Wirsma Arif Harahap; Teguh Aryandono
Journal:  Ann Med Surg (Lond)       Date:  2020-11-04

4.  Contralateral breast cancer risk in relation to tumor morphology and age-in which patients is preoperative MRI justified?

Authors:  N A de Glas; C C Engels; E Bastiaannet; W van de Water; S Siesling; A J M de Craen; C J H van de Velde; G J Liefers; J W S Merkus
Journal:  Breast Cancer Res Treat       Date:  2015-02-13       Impact factor: 4.872

5.  Prediction and clinical utility of a contralateral breast cancer risk model.

Authors:  Daniele Giardiello; Ewout W Steyerberg; Michael Hauptmann; Muriel A Adank; Delal Akdeniz; Carl Blomqvist; Stig E Bojesen; Manjeet K Bolla; Mariël Brinkhuis; Jenny Chang-Claude; Kamila Czene; Peter Devilee; Alison M Dunning; Douglas F Easton; Diana M Eccles; Peter A Fasching; Jonine Figueroa; Henrik Flyger; Montserrat García-Closas; Lothar Haeberle; Christopher A Haiman; Per Hall; Ute Hamann; John L Hopper; Agnes Jager; Anna Jakubowska; Audrey Jung; Renske Keeman; Iris Kramer; Diether Lambrechts; Loic Le Marchand; Annika Lindblom; Jan Lubiński; Mehdi Manoochehri; Luigi Mariani; Heli Nevanlinna; Hester S A Oldenburg; Saskia Pelders; Paul D P Pharoah; Mitul Shah; Sabine Siesling; Vincent T H B M Smit; Melissa C Southey; William J Tapper; Rob A E M Tollenaar; Alexandra J van den Broek; Carolien H M van Deurzen; Flora E van Leeuwen; Chantal van Ongeval; Laura J Van't Veer; Qin Wang; Camilla Wendt; Pieter J Westenend; Maartje J Hooning; Marjanka K Schmidt
Journal:  Breast Cancer Res       Date:  2019-12-17       Impact factor: 6.466

6.  Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer.

Authors:  Daniele Giardiello; Iris Kramer; Maartje J Hooning; Michael Hauptmann; Esther H Lips; Elinor Sawyer; Alastair M Thompson; Linda de Munck; Sabine Siesling; Jelle Wesseling; Ewout W Steyerberg; Marjanka K Schmidt
Journal:  NPJ Breast Cancer       Date:  2020-11-03

7.  Nomogram Predicts the Role of Contralateral Prophylactic Mastectomy in Male Patients With Unilateral Breast Cancer Based on SEER Database: A Competing Risk Analysis.

Authors:  Kunlong Li; Bin Wang; Zejian Yang; Ren Yu; Heyan Chen; Yijun Li; Jianjun He; Can Zhou
Journal:  Front Oncol       Date:  2021-04-29       Impact factor: 6.244

8.  Counterpoint: Angelina's choice-or the choice of anyone else in her place.

Authors:  P M Parikh
Journal:  South Asian J Cancer       Date:  2014-01

Review 9.  Contralateral prophylactic mastectomy: current perspectives.

Authors:  Katharine Yao; Mark Sisco; Isabelle Bedrosian
Journal:  Int J Womens Health       Date:  2016-06-22

10.  Worse characteristics can predict survival effectively in bilateral primary breast cancer: A competing risk nomogram using the SEER database.

Authors:  Kaiwen Shen; Longdi Yao; Jinli Wei; Zhou Luo; Wang Yu; Huamin Zhai; Jianwen Wang; Luhong Chen; Deyuan Fu
Journal:  Cancer Med       Date:  2019-10-30       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.